HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of technetium-99m pertechnetate scintigraphy in the management of extra-abdominal fibromatosis.

Abstract
The purpose of this study was to investigate technetium-99m pertechnetate (Tc-99m) as a tumor-scanning agent in patients with extra-abdominal fibromatosis, and to establish the sensitivity of this type of scintigraphy. Eleven patients with extra-abdominal fibromatosis were studied: all but one having postsurgical recurrences. Of the 11 patients, diagnosed histologically, 5 underwent repeated Tc-99m scintigraphic follow-up examinations. The injected 370 MBq Tc-99m gave us an early scintigram within 10 min and a delayed one 2 h later. For adequate comparison, the region of interest (ROI) of the scintigram was placed over the tumor. The tumor-to-background (T/BG) count ratio was computed. Extra-abdominal fibromatoses, even recurrences, were demonstrated scintigraphically in both the early and the delayed phase, in all 11 patients. The average T/BG ratio was 2.11 in the early scintigram and 2.15 in the delayed one. The sensitivity and the specificity were both 100%. Tc-99m scintigraphy has proved useful in detecting extra-abdominal fibromatoses and in the follow-up of patients.
AuthorsS Terui, T Terauchi, H Abe, Y Muramatsu, H Fukuma, Y Beppu, R Yokoyama
JournalSkeletal radiology (Skeletal Radiol) Vol. 24 Issue 5 Pg. 331-6 (Jul 1995) ISSN: 0364-2348 [Print] Germany
PMID7570152 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Sodium Pertechnetate Tc 99m
Topics
  • Adult
  • Female
  • Fibroma (diagnostic imaging, pathology)
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Neoplasm Recurrence, Local (diagnostic imaging, pathology)
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Sensitivity and Specificity
  • Sodium Pertechnetate Tc 99m
  • Soft Tissue Neoplasms (diagnostic imaging, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: